The Branched Stent Grafts Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Type (Iliac Stent, Others), By Application (Chimney, FEVAR, Others).
The Branched Stent Grafts market in 2024 serves the demand for advanced endovascular devices and interventional therapies used in the treatment of complex aortic aneurysms and thoracoabdominal aortic pathologies, providing targeted vessel reconstruction and blood flow restoration while preserving branch vessel patency and organ perfusion. Branched stent grafts are designed to accommodate the anatomical complexity of aortic arch and thoracoabdominal aneurysms by incorporating side branches or fenestrations to maintain blood flow to vital organs such as the brain, spinal cord, kidneys, and intestines, reducing the risk of ischemia and end-organ damage. Market dynamics are driven by factors such as the increasing prevalence of aortic aneurysms and aortic dissections, advancements in endovascular techniques and device design, and the growing adoption of minimally invasive and fenestrated/branched endovascular repair (F/BEVAR) procedures. Collaboration between medical device manufacturers, vascular surgeons, and interventional radiologists drives innovation and market growth in branched stent grafts, supporting improved patient outcomes and durability in the management of complex aortic pathologies.
A significant trend in the Branched Stent Grafts market is the ongoing advancements in endovascular techniques and technologies for the treatment of complex aortic aneurysms and thoracoabdominal aortic aneurysms (TAAAs). Endovascular repair using branched stent grafts offers a minimally invasive alternative to open surgery for patients with challenging anatomies or high surgical risks. Continuous innovations in stent graft designs, delivery systems, and imaging modalities have enabled more precise deployment, improved conformability, and enhanced outcomes for patients undergoing endovascular repair of branched aortic aneurysms.
A key driver for the Branched Stent Grafts market is the growing prevalence of aortic aneurysms and aortic diseases, particularly among aging populations and individuals with risk factors such as hypertension, smoking, and atherosclerosis. Aortic aneurysms, including TAAAs and thoracic aortic aneurysms (TAAs), pose a significant health risk due to the potential for rupture, dissection, or thrombosis, which can lead to life-threatening complications. As awareness and screening efforts increase, more patients are diagnosed with aortic aneurysms, driving the demand for innovative endovascular solutions such as branched stent grafts for aortic repair and reconstruction.
One potential opportunity in the Branched Stent Grafts market is the expansion of indications and applications beyond aortic aneurysms to include other complex aortic pathologies and anatomies. As endovascular techniques continue to evolve and gain acceptance, there is growing interest in utilizing branched stent grafts for the treatment of aortic dissections, aortic arch aneurysms, and other challenging aortic conditions. Additionally, advancements in imaging technology and computational modeling enable more accurate patient-specific planning and custom-designed stent grafts for complex anatomies. By leveraging these capabilities, manufacturers and healthcare providers can explore new therapeutic possibilities and address unmet clinical needs in the management of aortic diseases, thereby expanding the market potential for branched stent grafts.
By Type
By Application
-Chimney
-FEVAR
-Others
Geographical Analysis
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Branched Stent Grafts Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Branched Stent Grafts Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Branched Stent Grafts Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Branched Stent Grafts Market Size Outlook, $ Million, 2021 to 2030
3.2 Branched Stent Grafts Market Outlook by Type, $ Million, 2021 to 2030
3.3 Branched Stent Grafts Market Outlook by Product, $ Million, 2021 to 2030
3.4 Branched Stent Grafts Market Outlook by Application, $ Million, 2021 to 2030
3.5 Branched Stent Grafts Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Branched Stent Grafts Market Industry
4.2 Key Market Trends in Branched Stent Grafts Market Industry
4.3 Potential Opportunities in Branched Stent Grafts Market Industry
4.4 Key Challenges in Branched Stent Grafts Market Industry
5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Branched Stent Grafts Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Branched Stent Grafts Market Outlook By Segments
7.1 Branched Stent Grafts Market Outlook by Segments
By Type
Iliac Stent
Others
By Application
EVAR
-Chimney
-FEVAR
-Others
8 North America Branched Stent Grafts Market Analysis And Outlook To 2030
8.1 Introduction to North America Branched Stent Grafts Markets in 2024
8.2 North America Branched Stent Grafts Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Branched Stent Grafts Market size Outlook by Segments, 2021-2030
By Type
Iliac Stent
Others
By Application
EVAR
-Chimney
-FEVAR
-Others
9 Europe Branched Stent Grafts Market Analysis And Outlook To 2030
9.1 Introduction to Europe Branched Stent Grafts Markets in 2024
9.2 Europe Branched Stent Grafts Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Branched Stent Grafts Market Size Outlook By Segments, 2021-2030
By Type
Iliac Stent
Others
By Application
EVAR
-Chimney
-FEVAR
-Others
10 Asia Pacific Branched Stent Grafts Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Branched Stent Grafts Markets in 2024
10.2 Asia Pacific Branched Stent Grafts Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Branched Stent Grafts Market size Outlook by Segments, 2021-2030
By Type
Iliac Stent
Others
By Application
EVAR
-Chimney
-FEVAR
-Others
11 South America Branched Stent Grafts Market Analysis And Outlook To 2030
11.1 Introduction to South America Branched Stent Grafts Markets in 2024
11.2 South America Branched Stent Grafts Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Branched Stent Grafts Market size Outlook by Segments, 2021-2030
By Type
Iliac Stent
Others
By Application
EVAR
-Chimney
-FEVAR
-Others
12 Middle East And Africa Branched Stent Grafts Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Branched Stent Grafts Markets in 2024
12.2 Middle East and Africa Branched Stent Grafts Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Branched Stent Grafts Market size Outlook by Segments, 2021-2030
By Type
Iliac Stent
Others
By Application
EVAR
-Chimney
-FEVAR
-Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott
Alvimedica
Biotronik
Boston Scientific Corp
Cardinal Health (Cordis)
Cook Medical
Endocor GmbH
Eucatech AG
Medtronic
Merit Medical Systems
Terumo Corp
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Type
By Application
-Chimney
-FEVAR
-Others
Geographical Analysis
The global Branched Stent Grafts Market is one of the lucrative growth markets, poised to register a 8.8% growth (CAGR) between 2024 and 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Abbott, Alvimedica, Biotronik, Boston Scientific Corp, Cardinal Health (Cordis), Cook Medical, Endocor GmbH, Eucatech AG, Medtronic, Merit Medical Systems, Terumo Corp
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume